$150 Profit
CRBPLong Stock
Nice spike, glad i decided to get in before it was over. Corbus Pharmaceuticals' (CRBP) Investigational Drug Resunab(TM) Granted Fast Track Status by the U.S. FDA for the Treatment of Systemic Sclerosis. With that news the stock really had a nice little run.
| Date | Price | |
|---|---|---|
| Entry | 8/19/2015 | 3.30 |
| Exit | 8/19/2015 | 3.80 |
- Total Views192
- Position Size300
- Percentage15.15%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
